NRX Pharmaceuticals (NRXP)
NASDAQ:NRXP
Holding NRXP?
Track your performance easily

NRX Pharmaceuticals (NRXP) Financial Statements

319 Followers

NRX Pharmaceuticals Financial Overview

NRX Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.745; its P/E ratio is -0.52; NRX Pharmaceuticals is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $-0.64. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -7.90M$ -5.98M$ -4.43M$ -7.38M$ -11.05M
EBITDA$ -7.90M$ -5.98M$ -4.42M$ -7.38M$ -11.05M
Net Income Common Stockholders$ -7.90M$ -6.53M$ -4.33M$ -7.39M$ -11.05M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.90M$ 1.32M$ 4.59M$ 14.97M$ 16.51M
Total Assets$ 5.26M$ 3.79M$ 7.32M$ 19.81M$ 21.78M
Total Debt$ 8.59M$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ 6.70M$ -1.32M$ -4.59M$ -14.97M$ -16.51M
Total Liabilities$ 23.66M$ 18.86M$ 19.05M$ 22.62M$ 22.06M
Stockholders Equity$ -18.39M$ -15.07M$ -11.73M$ -2.81M$ -284.00K
Cash Flow-
Free Cash Flow$ -2.56M$ -3.67M$ -3.19M$ -7.81M$ -6.09M
Operating Cash Flow$ -2.56M$ -3.67M$ -3.19M$ -7.81M$ -6.09M
Investing Cash Flow--$ 1.00K$ 2.00K$ -4.00K
Financing Cash Flow$ 3.14M$ 395.00K$ -1.12M$ 6.27M$ 2.54M
Currency in USD

NRX Pharmaceuticals Earnings and Revenue History

NRX Pharmaceuticals Debt to Assets

NRX Pharmaceuticals Cash Flow

NRX Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis